Skip to main content
. 2013 Oct 31;110(2):399–408. doi: 10.1038/bjc.2013.688

Table 1. EIF5A2 staining and clinicopathological characteristics of 382 melanomas.

  EIF5A2 staining
 
Variables Positive number (%) Negative number (%) Total χ2- value P-value
All melanoma (n=382)
Age, years
⩽60 161 (81.3) 37 (18.7) 198 0.552 0.458
>60
144 (78.3)
40 (21.7)
184
 
 
Sex
Male 191 (83.4) 38 (16.6) 229 0.834 0.361
Female
122 (79.7)
31 (20.3)
153
 
 
AJCC stage
I 88 (69.3) 39 (30.7) 127 4.046 0.044a
II 103 (89.6) 12 (10.4) 115    
III 48 (88.9) 6 (11.1) 54    
IV
74 (86.0)
12 (14.0)
86
 
 
Primary melanoma (n=242)
Age, years
⩽61 95 (77.2) 28 (22.8) 123 0.429 0.512
>61
96 (80.7)
23 (19.3)
119
 
 
Sex
Male 105 (78.9) 28 (21.1) 133 0.000 1.000
Female
86 (78.9)
23 (21.1)
109
 
 
Tumour thickness (mm)
⩽2 94 (70.1) 40 (29.9) 134 13.90 <0.001
>2
97 (89.8)
11 (10.2)
108
 
 
Ulceration
Absent 146 (75.3) 48 (24.7) 194 7.911 0.005
Present
45 (93.7)
3 (6.3)
48
 
 
Subtype
Lentigo maligna 26 (70.3) 11 (29.7) 37 2.828 0.419
Superficial spreading 69 (77.5) 20 (22.5) 89    
Nodular 35 (85.4) 6 (14.6) 41    
Unspecified
61 (81.3)
14 (18.7)
75
 
 
Siteb
Sun protected 150 (79.8) 38 (20.2) 188 0.376 0.540
Sun exposed
41 (76.0)
13 (24.0)
54
 
 
Metastatic melanoma (n=140)
Age, years
⩽59 63 (86.3) 10 (13.7) 73 0.096 0.757
>59
59 (88.1)
8 (11.9)
67
 
 
Sex
Male 86 (89.6) 10 (10.4) 96 1.624 0.203
Female 36 (81.8) 8 (18.2) 44    

Abbreviation: AJCC=American Joint Committee on Cancer.

a

Comparison between AJCC stage I–II and III–IV, χ2-test.

b

Sun-protected sites: trunk, arm, leg and feet; sun-exposed sites: head and neck.